Telix Pharmaceuticals Limited (ASX:TLX)
13.13
-0.35 (-2.60%)
Oct 30, 2026, 4:13 PM AEDT
Telix Pharmaceuticals Employees
As of December 31, 2025, Telix Pharmaceuticals had 1,184 total employees, including 1,120 full-time and 64 part-time employees. The number of employees increased by 950 or 405.98% compared to the previous year. That makes Telix Pharmaceuticals the 13,713th largest employer in the world and 171st in Australia.
Employees
1,184
Change
950
Growth
405.98%
Revenue / Employee
1.12M AUD
Profits / Employee
42.03K AUD
Market Cap
4.46B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,184 | - | - | 1,120 | 64 |
| Mar 31, 2024 | 431 | 197 | 84.19% | 415 | 16 |
| Dec 31, 2022 | 234 | 76 | 48.10% | 234 | 0 |
| Dec 31, 2021 | 158 | - | - | 158 | 0 |
| Dec 31, 2017 | 9 | - | - | 9 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| CSL Limited | 29,000 |
| Mesoblast | 108 |
| Clarity Pharmaceuticals | 100 |
| Starpharma Holdings | 50 |
| Tetratherix | 25 |
Telix Pharmaceuticals News
- 9 days ago - Telix Pharmaceuticals falls -9.9% - TheFly
- 9 days ago - Telix Shares Sink Nearly 10% as Investors Shrug Off 19% Revenue Growth and Pixclara Launch in Third Quarter - International Business Times (Australia)
- 9 days ago - Telix Pharmaceuticals falls -10.1% - TheFly
- 10 days ago - Telix Pharma Reports 19% Q3 Revenue Growth, Reaffirms FY2026 Guidance And Advances Pipeline Programs - Nasdaq
- 10 days ago - Telix Pharmaceuticals Shares Slide 6.6% as Radiopharmaceutical Stock Extends Volatile 2026 Run on the ASX - International Business Times (Australia)
- 10 days ago - Telix Pharma Reports 19% Q3 Revenue Growth, Reaffirms FY2026 Guidance - Nasdaq
- 10 days ago - Telix Pharmaceuticals reports Q2 group revenue $245M vs. $206M last year - TheFly
- 10 days ago - Telix Pharmaceuticals reaffirms FY26 revenue and other income view $1B - TheFly